Accessibility Menu
Orexo Ab (publ) logo

Orexo Ab (publ)

(OTC) ORXOY

Current Price$1.80
Market CapN/A
Since IPO (2013)-93%
5 Year-63%
1 Year+22%
1 Month-12%

Orexo Ab (publ) Financials at a Glance

Market Cap

N/A

Revenue (TTM)

SEK 244.37M

Net Income (TTM)

-SEK 247.89M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-0.12 (Low)

Price

$1.80

Volume

1

Open

$1.80

Previous Close

$1.80

Daily Range

$1.80 - $1.80

52-Week Range

$1.48 - $4.05

Estimated Earnings Date

Jul 16, 2026

ORXOY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Orexo Ab (publ)

Industry

Pharmaceuticals

Headquarters

Uppsala, 751 05, SE

ORXOY Financials

Key Financial Metrics (TTM)

Gross Margin

-76%

Operating Margin

-94%

Net Income Margin

-1%

Return on Equity

0%

Return on Capital

-62%

Return on Assets

-41%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

0

Volume

1

Avg. Volume

5.156

Financials (TTM)

Gross Profit

-SEK 55.36M

Operating Income

-SEK 346.03M

EBITDA

-SEK 285.18M

Operating Cash Flow

SEK 172.57M

Capital Expenditure

SEK 0.00

Free Cash Flow

SEK 172.57M

Cash & ST Invst.

SEK 910.11M

Total Debt

SEK 490.97M

Orexo Ab (publ) Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

SEK 5.00M

-96.6%

Gross Profit

-SEK 4.29M

-103.4%

Gross Margin

-85.71%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

110

N/A

Net Income

-SEK 133.90M

-742.1%

EBITDA

-SEK 66.10M

-1220.3%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

SEK 386.20M

+224.3%

Total Debt

SEK 7.00M

-98.6%

Accounts Receivable

SEK 90.20M

-55.0%

Inventory

SEK 0.00

-100.0%

Long Term Debt

SEK 2.80M

-99.4%

Short Term Debt

SEK 8.39M

-55.9%

Return on Assets

-40.60%

N/A

Return on Invested Capital

-61.67%

N/A

Free Cash Flow

-SEK 33.40M

-718.5%

Operating Cash Flow

-SEK 33.30M

-637.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AAWHAscend Wellness Holdings, Inc.
$0.53-0.40%
HLTRFHLS Therapeutics Inc.
$3.15+0.00%
JUSHFJushi Holdings Inc.
$0.48+0.31%
CBWTFAuxly Cannabis Group Inc.
$0.12+7.14%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$15.71+0.02%
NOKNokia
$13.98-0.06%
SNAPSnap
$5.16-0.10%
RXTRackspace Technology
$6.21+0.05%

Questions About ORXOY

What is the current price of Orexo Ab (publ)?

Orexo Ab (publ) is trading at $1.80 per share.

What is the 52-week range for Orexo Ab (publ)?

Over the past 52 weeks, Orexo Ab (publ) has traded between $1.48 and $4.05.

How much debt does Orexo Ab (publ) have?

Orexo Ab (publ) total debt is unavailable.

How much cash does Orexo Ab (publ) have on hand?

Orexo Ab (publ) does not have cash on hand data available.

What is Orexo Ab (publ)’s dividend yield?

Orexo Ab (publ) does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.